September 19, 2024 02:05 PM EDT

House committee advances PRV reauthorization, but timing on final passage remains 'murky'

Zachary Brennan

Senior Editor

The House Energy & Commerce Committee unanimously advanced a bill late Wednesday that would reauthorize the rare pediatric priority review voucher (PRV) program through 2029 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

House committee advances PRV reauthorization, but timing on final passage remains 'murky'

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

Roche outlines commercial manufacturing strategy for GLP-1/GIP assets

Breaking down silos with a new quantitative approach to drug development

House com­mit­tee ad­vances PRV reau­tho­riza­tion, but tim­ing on fi­nal pas­sage re­mains 'murky'

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

House committee advances PRV reauthorization, but timing on final passage remains 'murky'